Boros, Benjamin D.
Schoch, Kathleen M.
Kreple, Collin J.
Miller, Timothy M. http://orcid.org/0000-0002-3424-5511
Funding for this research was provided by:
National Institutes of Health (RF1MH126723)
Robert Packard Center for ALS Research, Johns Hopkins University (n/a)
Target ALS (n/a)
Silicon Valley Community Foundation (221722)
U.S. Department of Defense (W81XWH1910117, W81XWH2010241)
Amyotrophic Lateral Sclerosis Association (n/a)
Hope Center for Neurological Disorders (n/a)
Ionis Pharmaceuticals (n/a)
This article is maintained by: Elsevier
Article Title: Antisense Oligonucleotides for the Study and Treatment of ALS
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-022-01247-2
Content Type: article
Copyright: Copyright © 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.